Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast Ca

ClinicalTrials.gov Show glossary Search for terms Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.

Related documents

• A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer#287380
• The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans#383613
• 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Pneumococcal Vaccine-Naïve Adults 60 Years of Age and Older in Japan, Korea, and Taiwan#28442
• tjhladish/covid-abm: Active Vaccination Experiment 2023-02-02#677956
• Study of Purified Vero Rabies Vaccine and Rabies Human Diploid Cell Vaccine in a Simulated Rabies Post-exposure Regimen#311192